APA

Zeidner J. F., Foster M. C., Blackford A. L., Litzow M. R., Morris L. E., Strickland S. A., Lancet J. E., Bose P., Levy M. Y., Tibes R., Gojo I., Gocke C. D., Rosner G. L., Little R. F., Wright J. J., Doyle L. A., Smith B. D. & Karp J. E. (20160321). Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia. : Haematologica.

Chicago

Zeidner Joshua F, Foster Matthew C, Blackford Amanda L, Litzow Mark R, Morris Lawrence E, Strickland Stephen A, Lancet Jeffrey E, Bose Prithviraj, Levy M Yair, Tibes Raoul, Gojo Ivana, Gocke Christopher D, Rosner Gary L, Little Richard F, Wright John J, Doyle L Austin, Smith B Douglas and Karp Judith E. 20160321. Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia. : Haematologica.

Harvard

Zeidner J. F., Foster M. C., Blackford A. L., Litzow M. R., Morris L. E., Strickland S. A., Lancet J. E., Bose P., Levy M. Y., Tibes R., Gojo I., Gocke C. D., Rosner G. L., Little R. F., Wright J. J., Doyle L. A., Smith B. D. and Karp J. E. (20160321). Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia. : Haematologica.

MLA

Zeidner Joshua F, Foster Matthew C, Blackford Amanda L, Litzow Mark R, Morris Lawrence E, Strickland Stephen A, Lancet Jeffrey E, Bose Prithviraj, Levy M Yair, Tibes Raoul, Gojo Ivana, Gocke Christopher D, Rosner Gary L, Little Richard F, Wright John J, Doyle L Austin, Smith B Douglas and Karp Judith E. Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia. : Haematologica. 20160321.